MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy shows promise for stubborn high cholesterol
Disease control Recruiting nowThis study looks at how well a combination of three cholesterol-lowering medicines (bempedoic acid, ezetimibe, and a statin) works in real-world patients with high cholesterol or mixed lipid problems. About 2,000 adults at high or very high risk will be followed for up to a year.…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New cholesterol drug showdown: could obicetrapib beat bempedoic acid?
Disease control Recruiting nowThis study tests a new drug called obicetrapib against another drug, bempedoic acid, to see which lowers 'bad' cholesterol more effectively. It involves 426 adults with high cholesterol who are already on maximum cholesterol medications and are at high risk for heart problems. Th…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: A. Menarini International Licensing S.A. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New combo pill for high cholesterol tested on thousands
Disease control Recruiting nowThis study is testing a fixed-dose combination of two cholesterol-lowering drugs, pitavastatin and ezetimibe, in over 8,600 people with high cholesterol or mixed lipid disorders. The goal is to see how well the combo works and how safe it is in real-world conditions, outside of a…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 15:30 UTC